Abstract：Objective To explore the effeet of Clopidogrel Hydrogen Sulfate Tablets in the treatment of eoronary heart disease.Methods A total of 60 patients with eoronary heart disease admitted to our hospital from Mareh 2016 to Mareh 2018 were seleeted as subjeets and were divided into eontrol group（30 eases）and study group（30 eases）aeeording to the random number table method.The eontrol group was treated with Aspirin Tablets，while the study group was treated with Clopidogrel Hydrogen Sulfate Tablets.The platelet reaetivity index（PRI），mean platelet aggregation rate（MPA），total effeetive rate of treatment and total ineidenee of adverse reaetions were eompared between the two groups before and after treatment.Results After treatment，the PRI level of patients in the study group was（25.30±5.20）%，MPA level was（40.25±4.25）%，both lower than those before treatment of（44.58±4.35）%and（65.35±6.10）%，the differenees were statistieally signifieant（P＜0.05）.After treatment，the PRI level of patients in the eontrol group was（32.80±5.45）%，MPA level was（52.33±5.35）%，both lower than those before treatment of（44.63±4.30）%and（65.40±6.03）%，the differenees were statistieally signifieant（P＜0.05）.The PRI and MPA levels of the study group were lower than those of the eontrol group after treatment，and the differenees were statistieally signifieant（P＜0.05）.The total effeetive rate in the study group was 96.67%，whieh was higher than that in the eontrol group（73.33%），and the differenee was statistieally signifieant（P＜0.05）.The total ineidenee of adverse reaetions in the study group was 13.33%，whieh was lower than that in the eontrol group（26.67%），and the differenee was statistieally signifieant（P＜0.05）.Conclusion Treatment of eoronary heart disease with Clopidogrel Hydrogen Sulfate Tablets ean signifieantly reduee PRI and MPA，improve elinieal treatment，and has a low ineidenee of adverse reaetions，whieh has an important elinieal applieation value.
京公网安备 11010502046607号